These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 12105210)
1. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003 [TBL] [Abstract][Full Text] [Related]
3. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. Grefhorst A; Elzinga BM; Voshol PJ; Plösch T; Kok T; Bloks VW; van der Sluijs FH; Havekes LM; Romijn JA; Verkade HJ; Kuipers F J Biol Chem; 2002 Sep; 277(37):34182-90. PubMed ID: 12097330 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol. Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067 [TBL] [Abstract][Full Text] [Related]
6. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression. Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219 [TBL] [Abstract][Full Text] [Related]
7. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376 [TBL] [Abstract][Full Text] [Related]
8. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146 [TBL] [Abstract][Full Text] [Related]
9. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. Murthy S; Born E; Mathur SN; Field FJ J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489 [TBL] [Abstract][Full Text] [Related]
10. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice. Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371 [TBL] [Abstract][Full Text] [Related]
11. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196 [TBL] [Abstract][Full Text] [Related]
12. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. Plösch T; Bloks VW; Terasawa Y; Berdy S; Siegler K; Van Der Sluijs F; Kema IP; Groen AK; Shan B; Kuipers F; Schwarz M Gastroenterology; 2004 Jan; 126(1):290-300. PubMed ID: 14699507 [TBL] [Abstract][Full Text] [Related]
13. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903 [TBL] [Abstract][Full Text] [Related]
14. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. van der Veen JN; van Dijk TH; Vrins CL; van Meer H; Havinga R; Bijsterveld K; Tietge UJ; Groen AK; Kuipers F J Biol Chem; 2009 Jul; 284(29):19211-9. PubMed ID: 19416968 [TBL] [Abstract][Full Text] [Related]
15. Phospholipid transfer protein is regulated by liver X receptors in vivo. Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004 [TBL] [Abstract][Full Text] [Related]
16. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists. Srivastava RAK; Cefalu AB; Srivastava NS; Averna M Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772 [TBL] [Abstract][Full Text] [Related]
17. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. de Vogel-van den Bosch HM; de Wit NJ; Hooiveld GJ; Vermeulen H; van der Veen JN; Houten SM; Kuipers F; Müller M; van der Meer R Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1171-80. PubMed ID: 18356535 [TBL] [Abstract][Full Text] [Related]
18. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381 [TBL] [Abstract][Full Text] [Related]
19. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468 [TBL] [Abstract][Full Text] [Related]
20. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]